Bernd Kuhn

Title: Bernd Kuhn: Innovator in Pharmaceutical Tablet Technology

Introduction

Bernd Kuhn is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative tablet formulations. His work focuses on enhancing the stability and disintegration properties of tablets, which are crucial for effective drug delivery.

Latest Patents

Kuhn holds a patent for "Mechanically-stable, readily-disintegratable tablets made of small preformed particles." This patent describes a process for manufacturing tablets that are both stable and capable of disintegrating readily upon ingestion. The tablets are made from small, preferably rounded, particles that contain a high percentage of active ingredients. Prior to compression, these particles are coated with a specific aqueous or aqueous/organic suspension that includes water-soluble polyvinyl alcohol, a disintegrant, and finely-divided cellulose. The resulting product is a stable yet readily-friable tablet that facilitates the effective delivery of active ingredients for oral ingestion.

Career Highlights

Kuhn's career is marked by his role at Merz + Co. GmbH & Co., where he has been instrumental in advancing pharmaceutical formulations. His innovative approach to tablet manufacturing has positioned him as a key figure in the industry. His work not only contributes to the efficiency of drug delivery systems but also enhances patient compliance through improved tablet characteristics.

Collaborations

Throughout his career, Bernd Kuhn has collaborated with esteemed colleagues such as Eberhard Nurnberg and Erhard Seiller. These collaborations have fostered a productive environment for innovation and have led to significant advancements in pharmaceutical technology.

Conclusion

In summary, Bernd Kuhn is a distinguished inventor whose work in the development of mechanically-stable, readily-disintegratable tablets has made a lasting impact on the pharmaceutical industry. His contributions continue to influence the way active ingredients are delivered to patients, ensuring better health outcomes.